Quest Diagnostics director granted 198 phantom units
WENTWORTH TIMOTHY C reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
WENTWORTH TIMOTHY C reported acquisition or exercise transactions in this Form 4 filing.
Quest Diagnostics director Timothy C. Wentworth received an award of 198 phantom stock units linked to Quest Diagnostics common stock. These units were credited on account of his elective deferral of director cash compensation under the company’s Amended and Restated Deferred Compensation Plan for Directors and will be payable in cash when his service as a director ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 198 shares
Grant/Award
1 txn
Insider
WENTWORTH TIMOTHY C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 198 | $0.00 | $0.00 |
Holdings After Transaction:
Phantom Stock Units — 198 contracts (Direct)
Footnotes (1)
- F1. Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
Key Figures
Phantom stock units granted: 198 units
Phantom units after transaction: 198 units
Transaction price per unit: $0.0000
3 metrics
Phantom stock units granted
198 units
Grant/award acquisition on 2026-04-01
Phantom units after transaction
198 units
Total phantom stock units following transaction
Transaction price per unit
$0.0000
Reported price for phantom stock unit grant
Key Terms
Phantom Stock Units, Deferred Compensation Plan for Directors, Grant, award, or other acquisition, Derivative security
4 terms
Phantom Stock Units financial
"Phantom stock units resulting from elective deferrals of a director's cash compensation"
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Deferred Compensation Plan for Directors financial
"pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors"
A deferred compensation plan for directors is an arrangement that lets board members postpone receiving part of their pay until a later date—often retirement or a set future time—so the money can grow or be paid under specified conditions. Think of it like directing a portion of your paycheck into a locked savings account that pays out later; investors care because it creates future cash or stock obligations, signals how the company motivates and retains leadership, and can affect shareholder value through timing of payouts or potential dilution.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Derivative security financial
"security_title: Phantom Stock Units, transaction_type: derivative"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did Quest Diagnostics (DGX) director Timothy C. Wentworth report on this Form 4?
He reported receiving 198 phantom stock units tied to Quest Diagnostics common stock. These units reflect an elective deferral of his director cash compensation under the company’s deferred compensation plan for directors.
Is the Quest Diagnostics (DGX) Form 4 transaction a stock purchase or sale?
No, the Form 4 shows a grant/award acquisition of phantom stock units, not an open-market stock purchase or sale. The units arise from deferred director cash compensation and are classified as a derivative security.
How many phantom stock units did the Quest Diagnostics (DGX) director receive?
Timothy C. Wentworth received 198 phantom stock units. Following this transaction, his reported balance for this derivative security is also 198 units, reflecting this compensation-related award.
When will the Quest Diagnostics (DGX) phantom stock units be paid to the director?
According to the filing, the phantom stock units become payable in cash upon Timothy C. Wentworth’s termination of service as a director. Payment timing is therefore tied to the end of his board service.
What plan governs the phantom stock units reported by Quest Diagnostics (DGX)?
The units arise under the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors. This plan allows directors to elect to defer cash compensation into phantom stock units payable in cash later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
